Aviceda Therapeutics
1 follower
Aviceda Therapeutics is a late-stage, pre-clinical stage biotech company focused on the next generation of immuno-modulators by harnessing the power of glycobiology to address the innate immune system and chronic non-resolving inflammation specifically and profoundly.
Org chart
Mohamed A. Genead
Collapse
David Callanan
SVP & Chief Medical Officer
Derek Kunimoto
Co-Founder & Chief Strategy Officer
Michael Tolentino
Co-Founder, CTO
Tarek S. Hassan
SVP & Chief Development Officer
Anitha Krishnan
Head of Biology Research
Amitkumar Lad
Director, CMC (head)
Sunny Christian
Associate Director: Technology Development & Quality
Director, Financial Planning & Analysis (fp&a)
Vacant position
Similar companies
Day One Biopharmaceuticals
1 follower
PMV Pharmaceuticals
1 follower
Applied Therapeutics
1 follower
Anthos Therapeutics
1 follower
ADARx Pharmaceuticals
2 followers
Ionis Pharmaceuticals
22 followers
Cytokinetics
11 followers
Avantor
10 followers
Charles River Laboratories
9 followers
Schrödinger
8 followers
Sage Therapeutics
4 followers
Discover companies